In vitro profiling of neuroblastoma cells using BH3-domain peptides revealed that, in addition to Mcl-1, also other antiapoptotic Bcl-2 proteins can confer resistance to chemotherapy (Goldsmith et al., 2010). The gene discussed is BCL2; the disease is neuroblastoma.